CClinicalTrials.gg
CompletedNCT04992299Updated Sep 2, 2026Results posted

Mindfulness-Based Intervention for Depression and Insulin Resistance in Adolescents

An interventional study of Mindfulness-Based Intervention and Cognitive-Behavioral Therapy in Type 2 Diabetes, Depression and Insulin Resistance, sponsored by Colorado State University. Completed at 4 sites in United States. Open to participants aged 12 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Colorado State University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
12 Years to 17 Years
Sex
All
01

Study summary

Rates of type 2 diabetes (T2D) in adolescents have escalated. Adolescent-onset is associated with greater health comorbidities and shorter life expectancy than adult-onset T2D. T2D is preventable by decreasing insulin resistance, a physiological precursor to T2D. T2D prevention standard-of-care is lifestyle intervention to decrease insulin resistance through weight loss; yet, this approach is insufficiently effective in adolescents. Adolescents at risk for T2D frequently experience depression, which predicts worsening insulin resistance and T2D onset, even after accounting for obesity. Mindfulness-based intervention (MBI) may offer a targeted, integrative health approach to decrease depression, and thereby, ameliorate insulin resistance in adolescents at risk for T2D. In a single-site, pilot randomized controlled trial (RCT), we established initial feasibility/acceptability of a 6-week group MBI program, Learning to BREATHE, in adolescents at risk for T2D. We demonstrated feasible single-site recruitment, randomization, retention, protocol adherence, and MBI acceptability/credibility in the target population. Our preliminary data also suggest MBI may lead to greater reductions in stress-related behavior, vs. CBT and a didactic/health education (HealthEd) control group. The current study is multisite, pilot RCT to test multisite fidelity, feasibility, and acceptability in preparation for a future multisite efficacy trial that will have strong external validity, timely recruitment, and long-term follow-up. Adolescents (N=120) at risk for T2D will be randomized to MBI vs. CBT vs. HealthEd and followed for 1-year. Specific aims are to: (1) test multisite fidelity of training and implementation of 6-week group MBI, CBT, and HealthEd, to teens at risk for T2D; (2) evaluate multisite feasibility/acceptability of recruitment, retention, and adherence for an RCT of 6-week group MBI, CBT, HealthEd with 6-week and 1-year follow-up; and (3) modify intervention training/implementation and protocol procedures in preparation for a future, fully-powered multisite efficacy RCT.

02

Conditions studied

  • Type 2 Diabetes
  • Depression
  • Insulin Resistance
  • Obesity
  • Adolescent Development

Keywords

  • Adolescent Development
  • Obesity
  • Type 2 Diabetes
03

In context

Diabetes Mellitus, Type 2

9,359 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,318 are open to participants now.

This study's enrollment of 120 is above the median of 80 across 7,525 interventional studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

Colorado State University is the lead sponsor of 112 studies on the registry; 19 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adolescent: Age 12-17 years
  • At-risk for T2D:

Overweight/obesity: BMI ≥85 percentile for age and sex Family history of T2D: ≥1 relative with T2D, prediabetes, or gestational diabetes in first- or second- degree relative, referring to a biological parent, sibling, aunt, uncle, or grandparent

  • Elevated depression symptoms: Center for Epidemiological Studies - Depression Scale (CES-D) total score >20
  • Good general health: Medical history/physical examination
  • Parent/guardian: Parent/guardian of qualifying participant

Exclusion criteria

Exclusion Criteria:

  • Major medical problem: including T2D, assessed at baseline/screening as fasting glucose ≥126 mg/dL or 2-hour glucose ≥200 mg/dL, or any other significant medical condition reported during the medical history/physical examination
  • Major psychiatric problem: Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 psychiatric diagnosis, including anorexia nervosa, bipolar disorder, bulimia nervosa, conduct disorder, major depressive disorder (MDD), obsessive compulsive disorder, panic disorder, posttraumatic stress disorder, psychosis, and substance/tobacco/alcohol use disorder
  • Regular medication use affecting mood, insulin, and/or weight: anti-anxiety medications, anti-depressants, anti-psychotics, insulin sensitizers, mood stabilizers, stimulants, and weight loss drugs
  • Active suicidal ideation or behavior
  • Regular psychotherapy or structured weight loss treatment
  • Pregnancy: as reported by adolescent participants (females)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Mindfulness-Based Intervention

    6-week group intervention, Learning to BREATHE, an adolescent mindfulness-based intervention derived from mindfulness-based stress reduction

    Behavioral: Mindfulness-Based Intervention

  • Active comparator
    Cognitive-Behavioral Therapy

    6-week group intervention, the Blues Program, a cognitive-behavioral intervention for adolescents with elevated symptoms of depression

    Behavioral: Cognitive-Behavioral Therapy

  • Other
    Health Education

    6-week group program providing didactic information on adolescent health topics

    Behavioral: Health Education

Interventions

  • BehavioralMindfulness-Based Intervention

    6-week mindfulness-based intervention of 6 weekly 1 hour group sessions

  • BehavioralCognitive-Behavioral Therapy

    6-week cognitive-behavioral therapy intervention of 6 weekly 1 hour group sessions

  • BehavioralHealth Education

    6-week health education didactic program of 6 weekly 1 hour group sessions

06

What researchers measure

Primary outcomes

  1. Intervention Fidelity

    Facilitators score ≥8 on adherence and competence ratings of MBI, CBT, and HealthEd adolescent group sessions (1=poor to 10=exceptional)

    Time frame: 12-months

  2. Recruitment Feasibility: Percentage of Eligible Adolescents Who Enroll

    ≥80% eligible adolescents will enroll

    Time frame: 12-months

Secondary outcomes

  1. Training Fidelity: Facilitator Knowledge After Training

    Facilitators score ≥80% on post-training knowledge/ competency tests of MBI, CBT, and HealthEd

    Time frame: 6-months

  2. Training Fidelity: Facilitator Adherence and Competence During Mock Sessions

    Facilitators score ≥8 on adherence and competence ratings of MBI, CBT, and HealthEd mock group sessions (1=poor to 10=exceptional)

    Time frame: 6-months

  3. Recruitment Feasibility

    Attainment of target N=120 within a 12-month period; CONSORT flow/number of months to reach recruitment goal

    Time frame: 24-months

  4. Intervention Feasibility: Attendance

    ≥80% adolescents attend 5:6 (80%) group MBI/CBT/HealthEd sessions

    Time frame: 6-weeks

  5. Intervention Acceptability: Likeability Ratings

    ≥80% adolescent liking ratings ≥4 (1=not at all to 5=extremely)

    Time frame: 6-weeks

  6. Retention Feasibility

    ≥80% at post-treatment follow-up and ≥70% at 1-year follow-up

    Time frame: 12-months

  7. Percentage Accuracy of Protocols

    ≥95% accuracy on standardized protocol checklists for all assessments

    Time frame: 18-months

  8. Intervention Acceptability: Credibility Ratings

    ≥80% adolescent credibility/helpfulness ratings ≥4 (1=not at all to 5=extremely)

    Time frame: 6-weeks

07

Results

Posted Apr 2, 2026
Limitations and caveats
By design, this multisite pilot and feasibility randomized controlled trial was centered on the assessment of training and implementation fidelity and feasibility and acceptability of the study protocol and interventions. Intervention effects cannot be determined until a powered trial is undertaken.

Participant flow

The first participant was enrolled on May 5, 2022, and enrollment was completed for this trial on September 9, 2023.

Participant flow — Overall Study
MilestoneMindfulness-Based InterventionCognitive-Behavioral TherapyHealth Education
Started374340
Completed313138
Not completed6122

Outcome measures

PrimaryIntervention Fidelity

Facilitators score ≥8 on adherence and competence ratings of MBI, CBT, and HealthEd adolescent group sessions (1=poor to 10=exceptional)

Time frame:
12-months
Reported as:
Median · Expert ratings ranging from 0-100%
Intervention Fidelity
Expert ratings ranging from 0-100%Mindfulness-Based InterventionCognitive-Behavioral TherapyHealth Education
Facilitator Competence90 (80 to 100)90 (80 to 92.5)97.5 (90 to 100)
Facilitator Adherence100 (95 to 100)90.5 (90 to 92.5)96 (90 to 100)
PrimaryRecruitment Feasibility: Percentage of Eligible Adolescents Who Enroll

≥80% eligible adolescents will enroll

Time frame:
12-months
Reported as:
Number · Number who chose to enroll
Recruitment Feasibility: Percentage of Eligible Adolescents Who Enroll
Number who chose to enrollTotal Who Enrolled
Recruitment Feasibility: Percentage of Eligible Adolescents Who Enroll120
SecondaryTraining Fidelity: Facilitator Knowledge After Training

Facilitators score ≥80% on post-training knowledge/ competency tests of MBI, CBT, and HealthEd

Time frame:
6-months
Reported as:
Count of participants · Participants
Training Fidelity: Facilitator Knowledge After Training
ParticipantsMindfulness-Based InterventionCognitive-Behavioral TherapyHealth Education
Training Fidelity: Facilitator Knowledge After Training11109
SecondaryTraining Fidelity: Facilitator Adherence and Competence During Mock Sessions

Facilitators score ≥8 on adherence and competence ratings of MBI, CBT, and HealthEd mock group sessions (1=poor to 10=exceptional)

Time frame:
6-months
Reported as:
Median · Expert ratings ranging from 0-100%
Training Fidelity: Facilitator Adherence and Competence During Mock Sessions
Expert ratings ranging from 0-100%Mindfulness-Based InterventionCognitive-Behavioral TherapyHealth Education
Facilitator Competence80 (80 to 85)86 (85 to 87.5)82.5 (80 to 93.8)
Facilitator Adherence85 (80 to 90)90 (90 to 92)80 (80 to 92)
SecondaryRecruitment Feasibility

Attainment of target N=120 within a 12-month period; CONSORT flow/number of months to reach recruitment goal

Time frame:
24-months
Reported as:
Number · Months
Recruitment Feasibility
MonthsTotal Sample
Recruitment Feasibility16
SecondaryIntervention Feasibility: Attendance

≥80% adolescents attend 5:6 (80%) group MBI/CBT/HealthEd sessions

Time frame:
6-weeks
Reported as:
Count of participants · Participants
Intervention Feasibility: Attendance
ParticipantsMindfulness-Based InterventionCognitive-Behavioral TherapyHealth Education
Intervention Feasibility: Attendance323130
SecondaryIntervention Acceptability: Likeability Ratings

≥80% adolescent liking ratings ≥4 (1=not at all to 5=extremely)

Time frame:
6-weeks
Reported as:
Number · Percentage
Intervention Acceptability: Likeability Ratings
PercentageMindfulness-Based InterventionCognitive-Behavioral TherapyHealth Education
Intervention Acceptability: Likeability Ratings58.855.962.8
SecondaryRetention Feasibility

≥80% at post-treatment follow-up and ≥70% at 1-year follow-up

Time frame:
12-months
Reported as:
Count of participants · Participants
Retention Feasibility
ParticipantsMindfulness-Based InterventionCognitive-Behavioral TherapyHealth Education
6-week/post-intervention follow-up353338
1-year follow-up313138
SecondaryPercentage Accuracy of Protocols

≥95% accuracy on standardized protocol checklists for all assessments

Time frame:
18-months

Results for this outcome have not been posted.

SecondaryIntervention Acceptability: Credibility Ratings

≥80% adolescent credibility/helpfulness ratings ≥4 (1=not at all to 5=extremely)

Time frame:
6-weeks
Reported as:
Number · Percentage
Intervention Acceptability: Credibility Ratings
PercentageMindfulness-Based InterventionCognitive-Behavioral TherapyHealth Education
Intervention Acceptability: Credibility Ratings5073.562.9

Adverse events

Collected over From baseline through end of the follow-up period, up to 1 year. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Mindfulness-Based Intervention0/37 (0%)0/37 (0%)29/37 (78.4%)
Cognitive-Behavioral Therapy0/43 (0%)1/43 (2.3%)27/43 (62.8%)
Health Education0/40 (0%)0/40 (0%)35/40 (87.5%)
Most frequent serious events
Most frequent serious events
EventMindfulness-Based InterventionCognitive-Behavioral TherapyHealth Education
Hospitalization for psychological concernsPsychiatric disorders0/371/430/40
Most frequent other events
Most frequent other events
EventMindfulness-Based InterventionCognitive-Behavioral TherapyHealth Education
Elevated lab resultsMetabolism and nutrition disorders19/3715/4326/40
Mental health concerns assessed at any point from baseline (within past year) to 1-year follow-upPsychiatric disorders16/3717/4322/40
Elevated blood pressure at any point from baseline to 1-year follow-upGeneral disorders4/374/438/40

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Mindfulness-Based InterventionCognitive-Behavioral TherapyHealth EducationTotal
<=18 years374340120
Between 18 and 65 years0000
>=65 years0000
Sex: Female, Male
Sex: Female, Male(Participants)Mindfulness-Based InterventionCognitive-Behavioral TherapyHealth EducationTotal
Female22252370
Male15181750
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Mindfulness-Based InterventionCognitive-Behavioral TherapyHealth EducationTotal
Hispanic or Latino17191854
Not Hispanic or Latino20242266
Unknown or Not Reported0000
BMI Status
BMI Status(Participants)Mindfulness-Based InterventionCognitive-Behavioral TherapyHealth EducationTotal
Overweight BMI 85-94th percentile97723
Obesity BMI >=95th percentile28363397
08

Study locations

4 sites
  • University of Colorado Denver/Children's Hospital Colorado
    Aurora, Colorado 80045, United States
  • Colorado State University
    Fort Collins, Colorado 80523, United States
  • Children's National Health System
    Washington D.C., District of Columbia 20010, United States
  • Uniformed Services University
    Bethesda, Maryland 20814, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Oct 24, 2023
  • Informed consent form · Oct 25, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Data will be made available upon reasonable request.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04992299
Lead sponsor
Colorado State University
Collaborators
National Center for Complementary and Integrative Health (NCCIH), University of Colorado, Denver, Children's National Research Institute, Uniformed Services University of the Health Sciences
Responsible party
Sponsor
First posted
Aug 5, 2021
Start date
May 5, 2022
Primary completion
Dec 21, 2024
Completion
May 26, 2025
Results posted
Apr 2, 2026
Last update
Sep 2, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion